CanaFarma Financial Statements From 2010 to 2025
| CNFHF Stock | USD 0.0001 0.00 0.00% |
Check CanaFarma Hemp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CanaFarma Hemp's main balance sheet or income statement drivers, such as , as well as many indicators such as . CanaFarma financial statements analysis is a perfect complement when working with CanaFarma Hemp Valuation or Volatility modules.
CanaFarma |
CanaFarma Hemp Products Company Shares Owned By Insiders Analysis
CanaFarma Hemp's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current CanaFarma Hemp Shares Owned By Insiders | 29.57 % |
Most of CanaFarma Hemp's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CanaFarma Hemp Products is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 29.57% of CanaFarma Hemp Products are shares owned by insiders. This is 94.8% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares owned by insiders for all United States stocks is 193.06% lower than that of the firm.
CanaFarma Hemp Products Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CanaFarma Hemp's current stock value. Our valuation model uses many indicators to compare CanaFarma Hemp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CanaFarma Hemp competition to find correlations between indicators driving CanaFarma Hemp's intrinsic value. More Info.CanaFarma Hemp Products is rated below average in operating margin category among its peers. It is rated below average in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CanaFarma Hemp's earnings, one of the primary drivers of an investment's value.About CanaFarma Hemp Financial Statements
CanaFarma Hemp stakeholders use historical fundamental indicators, such as CanaFarma Hemp's revenue or net income, to determine how well the company is positioned to perform in the future. Although CanaFarma Hemp investors may analyze each financial statement separately, they are all interrelated. For example, changes in CanaFarma Hemp's assets and liabilities are reflected in the revenues and expenses on CanaFarma Hemp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CanaFarma Hemp Products. Please read more on our technical analysis and fundamental analysis pages.
CanaFarma Hemp Products Corp. engages in growing, manufacturing, processing, and selling hemp oil in the United States. The company offers hemp-based products, such as chewing gum and tincture under the YOOFORIC brand. Canafarma Hemp is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in CanaFarma Pink Sheet
CanaFarma Hemp financial ratios help investors to determine whether CanaFarma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CanaFarma with respect to the benefits of owning CanaFarma Hemp security.